Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pingfu Fu

Showing results (71-80 of 268) with videos related to

Pageof 27
Sort By:
The Prostate|March 27, 2018
Ser-486/491 phosphorylation and inhibition of AMPKα activity is positively associated with Gleason score, metastasis, and castration-resistance in prostate cancer: A retrospective clinical studyMelissa A Babcook, Mahmut Akgul, Seunghee Margevicius, et al.
Molecular Carcinogenesis|July 27, 2012
Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1Rajnee Kanwal, Mitali Pandey, Natarajan Bhaskaran, et al.
Investigational New Drugs|January 15, 2014
Phase II trial of sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancerNeelesh Sharma, Nathan Pennell, Myles Nickolich, et al.
Research Square|May 27, 2024
Computational Pathology Assessments of Cardiac Stromal Remodeling: Clinical Correlates and Prognostic Implications in Heart TransplantationEliot Peyster, Cai Yuan, Sara Arabyarmohammadi, et al.
Neoplasia (New York, N.Y.)|July 17, 2004
Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progressionSanjeev Shukla, Gregory T MacLennan, Pingfu Fu, et al.
Heliyon|July 22, 2024
Image analysis Uncovers associations between immune landscape, collagen structure, and neoadjuvant chemotherapy in high-grade serous ovarian carcinomasArpit Aggarwal, Germán Corredor, Pingfu Fu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancerAnita Schwandt, Tarek Mekhail, Balazs Halmos, et al.
Hematological Oncology|June 1, 2022
Risk factors for cardiovascular events and mortality in patients diagnosed with diffuse large B-cell lymphoma and treated with anthracyclinesAkiva Diamond, Sabarish Ayyappan, Shufen Cao, et al.
Cancer Medicine|January 10, 2015
PIAS3 expression in squamous cell lung cancer is low and predicts overall survivalRime Abbas, Karen S McColl, Adam Kresak, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2025
Melphalan 140 mg/m<sup>2</sup> is Safe and Effective for Frail and Older Multiple Myeloma Patients With Comparable Rates of Minimal Residual Disease NegativityJeries Kort, Nikolas Naleid, Frank Oley, et al.
Pageof 27

Showing results (71-80 of 268) with videos related to

Sort By:
Pageof 27
The Prostate|March 27, 2018
Ser-486/491 phosphorylation and inhibition of AMPKα activity is positively associated with Gleason score, metastasis, and castration-resistance in prostate cancer: A retrospective clinical studyMelissa A Babcook, Mahmut Akgul, Seunghee Margevicius, et al.
Molecular Carcinogenesis|July 27, 2012
Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1Rajnee Kanwal, Mitali Pandey, Natarajan Bhaskaran, et al.
Investigational New Drugs|January 15, 2014
Phase II trial of sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancerNeelesh Sharma, Nathan Pennell, Myles Nickolich, et al.
Research Square|May 27, 2024
Computational Pathology Assessments of Cardiac Stromal Remodeling: Clinical Correlates and Prognostic Implications in Heart TransplantationEliot Peyster, Cai Yuan, Sara Arabyarmohammadi, et al.
Neoplasia (New York, N.Y.)|July 17, 2004
Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progressionSanjeev Shukla, Gregory T MacLennan, Pingfu Fu, et al.
Heliyon|July 22, 2024
Image analysis Uncovers associations between immune landscape, collagen structure, and neoadjuvant chemotherapy in high-grade serous ovarian carcinomasArpit Aggarwal, Germán Corredor, Pingfu Fu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancerAnita Schwandt, Tarek Mekhail, Balazs Halmos, et al.
Hematological Oncology|June 1, 2022
Risk factors for cardiovascular events and mortality in patients diagnosed with diffuse large B-cell lymphoma and treated with anthracyclinesAkiva Diamond, Sabarish Ayyappan, Shufen Cao, et al.
Cancer Medicine|January 10, 2015
PIAS3 expression in squamous cell lung cancer is low and predicts overall survivalRime Abbas, Karen S McColl, Adam Kresak, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2025
Melphalan 140 mg/m<sup>2</sup> is Safe and Effective for Frail and Older Multiple Myeloma Patients With Comparable Rates of Minimal Residual Disease NegativityJeries Kort, Nikolas Naleid, Frank Oley, et al.
Pageof 27